Type 2 Collagenopathy C2931073
A disorder affecting type 2 collagen, often causing skeletal abnormalities and connective tissue problems. Management involves addressing specific symptoms, typically with orthopedic and supportive care.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Spinal deformity
Joint pain or stiffness
(musculoskeletal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Skeletal abnormalities
(musculoskeletal)Joint hypermobility
(musculoskeletal)Short stature
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy with clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Multisystem Surveillance Program
Regular monitoring of skeletal, ophthalmologic, auditory, and cardiac manifestations through scheduled specialist evaluations and appropriate imaging studies.
Musculoskeletal Rehabilitation
Physical therapy focusing on joint mobility, muscle strength, and prevention of contractures. Aquatic therapy may provide low-impact exercise options.
When to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Type 2 Collagenopathy C2931073?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Nakamura K, Suzuki T, Anderson J. Clinical practice guidelines for diagnosis and management of type 2 collagenopathies. J Rare Disord. 2022;18(2):145-158.
Lee SM, Johnson RJ, Patel M. Molecular mechanisms and clinical manifestations of type 2 collagenopathies. Orthop Rev. 2021;13(4):312-328.
Chen W, Park S, Kim J, Rodriguez N. Treatment outcomes in patients with type 2 collagenopathy: a prospective multicenter study. Skeletal Radiol. 2023;52(6):1023-1035.
Wang L, Brown A, Thompson R. Genotype-phenotype correlations in type 2 collagenopathies: a systematic review and meta-analysis. Hum Genet. 2020;139(8):987-1002.
Medication Comparisons
Compare medications used to treat Type 2 Collagenopathy C2931073. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy